Neurology Grand Rounds: Dr Raphael Schneider

Faculty Speaker Series: Dr Raphael Schneider

Speaker: Raphael Schneider, MD, PhD, FRCPC, CIP
Neurologist, St. Michael's Hospital, Unity Health
Associate Scientist, Keenan Research Centre for Biomedical Science
Assistant Professor, University of Toronto

Dr. Raphael Schneider is an Assistant Professor in the Department of Medicine and an Associate Scientist at the Keenan Research Centre for Biomedical Science (Unity Health Toronto). He completed his neurology residency and PhD at the University of Toronto and his postdoctoral studies at the Université de Montreal. He has recently been awarded an operating grant from the MS Society of Canada to study immune system alterations in people with radiologically isolated syndrome. 

Topic: The earliest signs of multiple sclerosis

Objectives: 

• To identify MS before the onset of clinical symptoms

• To interpret prognostic imaging biomarkers in MS

• To evaluate novel fluid biomarkers for MS

No single test can provide a diagnosis of multiple sclerosis (MS). Earlier diagnosis of MS would allow for timely discussions about the nature of MS and its management. Emerging MRI and fluid biomarkers may help clinicians make a diagnosis of MS earlier than ever before.

These rounds are generously supported by Mrs. Alix and Mr. Jim Arnett, and through formal partnership with the Division of Neurology; Alexion, Amylyx, Biogen, EMD Serono, Grifols, Novartis, Paladin Labs, Roche, Sanofi Genzyme, Teva and UCB.